|
|
Legal status
Patent expired
| (51) | INT.CL. | C12N 15/19 | (2006.01) |
| C07K 14/52 | (2006.01) | ||
| C12N 5/10 | (2006.01) | ||
| C12N 1/21 | (2006.01) | ||
| A61K 38/19 | (2006.01) | ||
| A61P 7/06 | (2006.01) |
| (11) | Number of the document | 2319928 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10011689.6 |
| Date of filing the European patent application | 1999-10-22 | |
| (97) | Date of publication of the European application | 2011-05-11 |
| (45) | Date of publication and mention of the grant of the patent | 2013-03-27 |
| (46) | Date of publication of the claims translation | 2013-08-26 |
| (30) | Number | Date | Country code |
| 105348 P | 1998-10-23 | US |
| (72) |
Liu, Chuan-Fa, US
Feige, Ulrich, US
Cheetham, Janet, US
|
| (73) |
Kirin-Amgen, Inc.,
One Amgen Center Drive, Thousand Oaks CA 91320,
US
|
| (74) |
Ramunė GARŠVIENĖ,
Dūkštų g. 28-20, LT-07171 Vilnius,
LT
|
| (54) | Dimerinio trombopoetino peptido mimetikai, besijungiantys prie MP1 receptoriaus ir turintys trombopoetinį aktyvumą |
| Dimeric thrombopoietin peptide mimetics binding to MP1 receptor and having thrombopoietic activity |
| Payment date | Validity (years) | Amount | |
| 2018-09-25 | 20 | 347.00 EUR |